StockData
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

Lantheus Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$99.92+0.22 (+0.22%)

Close on Oct 19, 2026

Market cap
$6.75B
P/E (TTM)
24.2
Dividend yield
–

Lantheus Holdings, Inc. balance sheet

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
60.1%
Operating margin
19.4%
Net margin
17.7%
Return on equity, FY2025
21.4%

Financial strength

Current ratio
3.06
Debt to equity
0.44
Debt to assets
23.6%
Cash to current liabilities
176.7%

Valuation

P/E ratio
24.2
Price to sales
4.33
Price to book
5.14
Dividend yield
–